Medtronic to Expand Heart Failure Portfolio with Acquisition of Heartware International Medtronic plc Extends Clinical and Commercial Leadership Into Growing Circulatory Support Sector DUBLIN and FRAMINGHAM, Mass. – June 27, 2016 – Medtronic plc (NYSE: MDT), the global leader in medical technology, and HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory Continue Reading
Blog
Medtronic acquires Heartware International
From Medtronic Micra Transcatheter Pacemaker System
This is a brief overview of information related to FDA’s approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA’s approval. http://www.medtronic.com/us-en/healthcare-professionals/products/cardiac-rhythm/pacemakers/micra-pacing-system.html
Latest updates on TMVI
CardiAQ™ Valve Technologies Reports First-in-Human Percutaneous Transfemoral, Transseptal Implantation with Its Second Generation Transcatheter Bioprosthetic Mitral Heart Valve Nearly 50% of patients suffering from a diseased mitral heart valve with severe, symptomatic regurgitation are currently denied open-heart surgery because it is considered too risky; in the future, percutaneous Transcatheter Mitral Valve Implantation (TMVI) may offer Continue Reading
Incoming a pacemaker without batteries – Health
Incoming a pacemaker without batteries It is powered with heart beat, it will allow to avoid surgical interventions to substitute batteries to improve patients comfort reducing risks Heart risks also among joung people 16:21 – An innovative pacemaker able to operate without batteries, supplied with the beat of the heart. A step forward in hi-tech Continue Reading
Fat outside arteries affects the onset of coronary desease-Medimagazine
Il grasso al di fuori delle arterie, influenza l’insorgenza della malattia coronarica » Medimagazine. on 22 April 2012 Some researchers confirmed that the fat that surrounds the outer part of the arteries, and in particular the left coronary artery, can influence the onset of coronary artery disease or atherosclerosis. The results of the research were Continue Reading
PHARMASTAR :: new confirmation for bio-absorbable stents
07 June 2012 Bioabsorbable polymer and drug eluting stents can reduce the risk of thrombosis intrastent to 4 years in patients undergoing coronary angioplasty primary. These results come from an analysis recently published on European Heart Journal. Data of individual patients from three randomised clinical trials, multicenter and large-scale (ISAR-TEST 3, ISAR-TEST 4, and LEADERS), Continue Reading
Announced development of fully implantable ventricular assist system.
HeartWare and Dualis MedTech Announce Agreement to Develop Fully Implantable Ventricular Assist System FRAMINGHAM, Mass. and SYDNEY, Jan. 9, 2012 /PRNewswire/ — HeartWare International, Inc. (NASDAQ: HTWR – ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, and Dualis MedTech GmbH, a subsidiary Continue Reading
Stent
They are small tubes inserted into coronary arteries during transcutaneous angioplasty intervention and some of them are able to elute drugs into vessel lumen wall to prevent restenosis. Coronary angioplasty has revolutionised the treatment of coronary atherosclerotic disease since its appearance in the mid 70. The introduction of coronary stenting has represented an important step Continue Reading